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In the gastrointestinal tract, the contraction of the muscle
(longitudinal and circular segments) is regulated by
neuronal inhibitory or excitatory transmission
(Enteric Nervous System) or by slow waves from
interstitial cells of Cajal (ICCs). Loperamide acts as
antidiarrheal solution, but its mechanism of action is
unclear.
The objective is to determine the effect of loperamide in
rat colon in order to evaluate potential mechanisms of
action.
 7 rat colon in organ bath.
Loperamide concentration ranges from 10-9M to
10-4M.
 Tension (g) of contraction (spontaneous and
excitatory motility) and AUC (inhibitory motility).
One-way ANOVA and non-linear regression
(loperamide pharmacodynamics).
Datawin 2001 and GraphPad Prism.
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INTRODUCTION AND OBJECTIVES MATERIAL AND METHODS
Table1: Summary of protocols used in the experiment. N refers to
number of segments in circular (C) and longitudinal (L) layers. We use non-
adrenergic, non-cholinergic (NANC) conditions and tetrodotoxin (TTX) or
Krebs solution with L-NNA and MRS2500
 There is a decrease of tension in all experiments 
 Frequency of contractions seems to increase 
 There is none or little effect until 10-6M
RESULTS
Figure 1: Organ bath log showing the effect of different loperamide concentration in spontaneous 
motility (A, B), neural mechanism - contraction (C, D) and relaxation (E, F) in both enteric muscle 
layers. In inhibitory experiments, EFS is applied every 10 minutes.
Figure 3: Dose-response pharmacodynamics with loperamide in the excitatory (A) and spontaneous 
(B) experiments. Much of the variation in the results would be due to the model (R2 > 0.60 in all cases).
 Highly significative
in both excitatory
and spontaneous
experiments (p <
0,0001).
 Significative in
longitudinal inhibitory
study (p = 0.0086).
 Not significative in
circular inhibitory
study.
 Effect starts at 10-6M
and is maximum at 10-
4M.
In all experiments there is
a decrease of the
contraction response.
As the AUC depends on
the amplitude of the
contractions, the
difference between the
doses in the inhibitory
experiment is significative
but not relevant.
Figure 2: Graph showing the effects of loperamide on the percentage of response in different 
protocols and its standard mean deviation (SEM). Carried out with excitatory stimulation (A, B), TTX 
and no stimulation (C, D), and with inhibitory stimulation (E, F). 
Figure 4: Scheme representing the potential routes of action of loperamide in the
gastrointestinal smooth muscle. Voltage-dependent sodium channels (NaV), potassium channels (K+),
calcium channels type N (Ca2+N) and L (Ca2+L), opioid receptors (μ rec and κ rec), tachykinins (TK),
acetylcholine (ACH), muscarinic receptors (Mrec), neurokinin receptors (NK2 rec), tetrodotoxin (TTX),
guanylate cyclase (GC) nitrergic inhibitory pathway from nitric oxide synthase (NOS) that produces nitric
oxide (NO), via purinergic (ATP, PACAP and VIP), which acts in ionic (P2x) and metabotropic (P2Y) receptors
and vasopressin receptors (VPA rec).
 μ receptors agonist
 Blockage of L-type calcium channels
 Blockage of sodium channels
 Interference with calmodulin
DISCUSSION
 Loperamide causes a decrease in tension in the contraction of the smooth 
longitudinal and circular enteric muscles, both when stimulated by excitatory 
cholinergic motoneurons, and when it contracts spontaneously.
 Its effect on inhibitory neurotransmission is less apparent since spontaneous 
activity is inhibited, which makes it difficult to assess .
 The mechanism of action can be through μ-type receptors, although we do not 
rule out the pharmacological action on other pathways such as L-type calcium 
channels. Further studies are needed to confirm the receptors involved in the 
effects of loperamide at the gastrointestinal level.
Graph of the effects of loperamide on the percentage of response in the different protocols and its standard mean deviation (SEM).
